Clinical Trial Update: Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) [Phase 3]

View source ↗

Summary

Phase 3 trial update for OVERCOME evaluating treatment of extensively drug-resistant gram-negative infections; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection
• Pneumonia

Snippet

Sponsor: University of Michigan | Conditions: Pneumonia, Blood Stream Infection | Phase 3 | Status: COMPLETED | Results posted: 2021-11-30